中文产业新闻评分51Chinese source
诺和诺德以3亿美元首付引进恒瑞口服GLP-1/GIP双激动剂HRS-1596
诺和诺德3亿美元首付引进口服GLP-1/GIP双激动剂；阿斯利康20亿美元投资Summit
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
诺和诺德3亿美元首付引进口服GLP-1/GIP双激动剂；阿斯利康20亿美元投资Summit
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.